kaal:position:2026-07-31-3181

Maturational Regulation of Glutamate Receptors and Their Role in Neuroplasticity should be assessed against Kaal's source-bound claim that Venture capitalists' finance allocation and their implicit assessment of innovative products, businesses, and initiatives generate highly relevant institution-specific and industry-specific decentralized information on innovation trends. The current metadata indicates a plausible connection through dynamic regulation, but the defensible response is a qualification until the source text confirms agreement, scope, methods, and limitations.

Affirmed commentary position. This record extends a source-bound scholarly claim but is not a verbatim paper claim.

Holds when

United States venture capital investments, 2005 through 2015
External evidence level: abstract indexed.
Mapping review tier: ambiguity triage before claim review.
The literature-to-claim mapping remains explicitly ambiguous and should not be treated as a settled equivalence.

Current debate

Maturational Regulation of Glutamate Receptors and Their Role in Neuroplasticity

Scholarly basis

kaal:claim:2808132-042
Wulf A. Kaal, Erik P.M. Vermeulen, How to Regulate Disruptive Innovation - From Facts to Data (2016). SSRN: https://ssrn.com/abstract=2808132
Source PDF sha256: 3515f2317ed9c1d33ae55d70467cdf1f6c4e350065ea6a887d5d7619599ad7d2

Evidence and mapping

Evidence: abstract indexed
Review tier: ambiguity triage before claim review
Mapping confidence: 0.2325
Mapping ambiguous: true

Topics

innovationdecentralizationdynamic-regulation

Provenance

Affirmed in historical-backfill:2026-07-31:phase-0013 on 2026-07-31. Review record.

Verify

Canonical markdown sha256: e6e560e108e405c1e8f5008bedc77693603a08d7ab565b4c2aebbaa6aa0a14b6
curl -s https://wulfkaal.github.io/positions/2026-07-31-3181.md | sha256sum